Copper
•Last Updated: September 28 2022
Copper is an essential mineral for antioxidative enzymes in the human body. While vital, it appears to be sufficient in the human diet and water supply with little evidence concerning its usefulness as a supplement. Excess copper is involved in some cases of Alzheimer's.
Copper is most often used for
Last Updated: September 28 2022
Copper is an essential trace mineral that is used in a variety of processes in the body. The major function for copper is in catalyzing oxidation-reduction (REDOX) reactions important for the activity of a number of enzymes. Although copper is essential to health, most Western diets meet the recommended intake, making supplementation unnecessary in most healthy individuals.
Cases where copper deficiency may occur include patients who have undergone gastric bypass as well as chronic users of proton pump inhibitors, both of which interfere with copper absorption. Also, high levels of zinc intake may increase production of a protein known as metallothionein that can bind copper and reduce its levels in the body.
Although the REDOX chemistry catalyzed by copper is essential for a number of immune functions, copper also may play a role in Alzheimer's disease. Copper levels generally rise in the body with age, but seem to rise more sharply in those with Alzheimer's. Moreover, copper levels have been linked to Alzheimer's symptom severity, leading some to suggest that a lower copper intake may benefit the elderly.
Supplementation of copper tends to be in the 1mg dosage, but at this moment in time there seems to be no major supplemental purpose of copper in any form. Doses of 1mg appear to be safe over the short term while higher doses should be avoided.
Latest ResearchRead all studies
1.^Subar AF1, Krebs-Smith SM, Cook A, Kahle LLDietary sources of nutrients among US adults, 1989 to 1991J Am Diet Assoc.(1998 May)
2.^Sadhra SS1, Wheatley AD, Cross HJDietary exposure to copper in the European Union and its assessment for EU regulatory risk assessmentSci Total Environ.(2007 Mar 15)
3.^Abdel-Mageed AB1, Oehme FWA review of the biochemical roles, toxicity and interactions of zinc, copper and iron: II. CopperVet Hum Toxicol.(1990 Jun)
5.^Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc.()
6.^Ridge PG1, Zhang Y, Gladyshev VNComparative genomic analyses of copper transporters and cuproproteomes reveal evolutionary dynamics of copper utilization and its link to oxygenPLoS One.(2008 Jan 2)
7.^Liochev SI1, Fridovich IMechanism of the peroxidase activity of Cu, Zn superoxide dismutaseFree Radic Biol Med.(2010 Jun 15)
8.^Tainer JA, Getzoff ED, Richardson JS, Richardson DCStructure and mechanism of copper, zinc superoxide dismutaseNature.(1983 Nov 17-23)
9.^Getzoff ED, Tainer JA, Weiner PK, Kollman PA, Richardson JS, Richardson DCElectrostatic recognition between superoxide and copper, zinc superoxide dismutaseNature.(1983 Nov 17-23)
10.^Liochev SI1, Fridovich ICO2, not HCO3-, facilitates oxidations by Cu,Zn superoxide dismutase plus H2O2Proc Natl Acad Sci U S A.(2004 Jan 20)
11.^Chen SN, Hoffman MZRate constants for the reaction of the carbonate radical with compounds of biochemical interest in neutral aqueous solutionRadiat Res.(1973 Oct)
12.^Medinas DB1, Cerchiaro G, Trindade DF, Augusto OThe carbonate radical and related oxidants derived from bicarbonate bufferIUBMB Life.(2007 Apr-May)
14.^Liochev SI1, Fridovich ICarbon dioxide mediates Mn(II)-catalyzed decomposition of hydrogen peroxide and peroxidation reactionsProc Natl Acad Sci U S A.(2004 Aug 24)
15.^Blakley BR, Hamilton DLThe effect of copper deficiency on the immune response in miceDrug Nutr Interact.(1987)
16.^Koller LD, Mulhern SA, Frankel NC, Steven MG, Williams JRImmune dysfunction in rats fed a diet deficient in copperAm J Clin Nutr.(1987 May)
19.^Dietary Reference Intake for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids.()
20.^Squitti R1, Siotto M2, Polimanti R3Low-copper diet as a preventive strategy for Alzheimer's diseaseNeurobiol Aging.(2014 Sep)
21.^Barnard ND1, Bush AI2, Ceccarelli A3, Cooper J4, de Jager CA5, Erickson KI6, Fraser G7, Kesler S8, Levin SM9, Lucey B10, Morris MC11, Squitti R12Dietary and lifestyle guidelines for the prevention of Alzheimer's diseaseNeurobiol Aging.(2014 Sep)
22.^Turnlund JR1, Keyes WR, Anderson HL, Acord LLCopper absorption and retention in young men at three levels of dietary copper by use of the stable isotope 65CuAm J Clin Nutr.(1989 May)
23.^Cunnane SC, Horrobin DF, Manku MSContrasting effects of low or high copper intake on rat tissue lipid essential fatty acid compositionAnn Nutr Metab.(1985)
25.^Kumar N1, McEvoy KM, Ahlskog JEMyelopathy due to copper deficiency following gastrointestinal surgeryArch Neurol.(2003 Dec)
26.^Plantone D1, Renna R2, Primiano G3, Shukralla A4, Koudriavtseva T2PPIs as possible risk factor for copper deficiency myelopathyJ Neurol Sci.(2015 Jan 12)
27.^Sakai N1, Shin T, Schuster R, Blanchard J, Lentsch AB, Johnson WT, Schuschke DAMarginal copper deficiency increases liver neutrophil accumulation after ischemia/reperfusion in ratsBiol Trace Elem Res.(2011 Jul)
28.^Li Y1, Wang L, Schuschke DA, Zhou Z, Saari JT, Kang YJMarginal dietary copper restriction induces cardiomyopathy in ratsJ Nutr.(2005 Sep)
29.^Wildman RE1, Hopkins R, Failla ML, Medeiros DMMarginal copper-restricted diets produce altered cardiac ultrastructure in the ratProc Soc Exp Biol Med.(1995 Oct)
30.^Schuschke DA1, Percival SS, Saari JT, Miller FNRelationship between dietary copper concentration and acetylcholine-induced vasodilation in the microcirculation of ratsBiofactors.(1999)
31.^Schuschke LA1, Saari JT, Miller FN, Schuschke DAHemostatic mechanisms in marginally copper-deficient ratsJ Lab Clin Med.(1995 Jun)
32.^Schuschke DA1, Adeagbo AS, Patibandla PK, Egbuhuzo U, Fernandez-Botran R, Johnson WTCyclooxygenase-2 is upregulated in copper-deficient ratsInflammation.(2009 Oct)
33.^Lentsch AB1, Kato A, Saari JT, Schuschke DAAugmented metalloproteinase activity and acute lung injury in copper-deficient ratsAm J Physiol Lung Cell Mol Physiol.(2001 Aug)
34.^Schuschke DA1, Percival SS, Lominadze D, Saari JT, Lentsch ABTissue-specific ICAM-1 expression and neutrophil transmigration in the copper-deficient ratInflammation.(2002 Dec)
35.^Elsherif L1, Ortines RV, Saari JT, Kang YJCongestive heart failure in copper-deficient miceExp Biol Med (Maywood).(2003 Jul)
36.^Davidson J1, Medeiros DM, Hamlin RLCardiac ultrastructural and electrophysiological abnormalities in postweanling copper-restricted and copper-repleted rats in the absence of hypertrophyJ Nutr.(1992 Jul)
37.^Elsherif L1, Wang L, Saari JT, Kang YJRegression of dietary copper restriction-induced cardiomyopathy by copper repletion in miceJ Nutr.(2004 Apr)
38.^Plantone D, Primiano G, Renna R, Restuccia D, Iorio R, Patanella KA, Ferilli MN, Servidei SCopper deficiency myelopathy: A report of two casesJ Spinal Cord Med.(2014 Oct 24)
39.^Kumar N1, Gross JB Jr, Ahlskog JECopper deficiency myelopathy produces a clinical picture like subacute combined degenerationNeurology.(2004 Jul 13)
40.^Kumar N1, Ahlskog JE, Klein CJ, Port JDImaging features of copper deficiency myelopathy: a study of 25 casesNeuroradiology.(2006 Feb)
41.^Imani S1, Moghaddam-Banaem L, Roudbar-Mohammadi S, Asghari-Jafarabadi MChanges in copper and zinc serum levels in women wearing a copper TCu-380A intrauterine deviceEur J Contracept Reprod Health Care.(2014 Feb)
42.^Rodrigues da Cunha AC1, Dorea JG, Cantuaria AAIntrauterine device and maternal copper metabolism during lactationContraception.(2001 Jan)
43.^Gollan GLStudies on the nature of complexes formed by copper with human alimentary secretions and their influence on copper absorption in the ratClin Sci Mol Med.(1975 Sep)
44.^VANCAMPEN DR, MITCHELL EAABSORPTION OF CU-64, ZN-65, MO-99, AND FE-59 FROM LIGATED SEGMENTS OF THE RAT GASTROINTESTINAL TRACTJ Nutr.(1965 Jun)
45.^Fields M, Craft N, Lewis C, Holbrook J, Rose A, Reiser S, Smith JCContrasting effects of the stomach and small intestine of rats on copper absorptionJ Nutr.(1986 Nov)
47.^Hill GM, Brewer GJ, Juni JE, Prasad AS, Dick RDTreatment of Wilson's disease with zinc. II. Validation of oral 64copper with copper balanceAm J Med Sci.(1986 Dec)
48.^Murgia C1, Vespignani I, Cerase J, Nobili F, Perozzi GCloning, expression, and vesicular localization of zinc transporter Dri 27/ZnT4 in intestinal tissue and cellsAm J Physiol.(1999 Dec)
49.^Árus D1, Dancs Á, Nagy NV, Gajda TA comparative study on the possible zinc binding sites of the human ZnT3 zinc transporter proteinDalton Trans.(2013 Sep 7)
50.^Arredondo M1, Muñoz P, Mura CV, Nùñez MTDMT1, a physiologically relevant apical Cu1+ transporter of intestinal cellsAm J Physiol Cell Physiol.(2003 Jun)
51.^Espinoza A1, Le Blanc S, Olivares M, Pizarro F, Ruz M, Arredondo MIron, copper, and zinc transport: inhibition of divalent metal transporter 1 (DMT1) and human copper transporter 1 (hCTR1) by shRNABiol Trace Elem Res.(2012 May)
52.^Gao S1, Yin T2, Xu B2, Ma Y2, Hu M2Amino acid facilitates absorption of copper in the Caco-2 cell culture modelLife Sci.(2014 Jul 25)
54.^Turnlund JR, King JC, Gong B, Keyes WR, Michel MCA stable isotope study of copper absorption in young men: effect of phytate and alpha-celluloseAm J Clin Nutr.(1985 Jul)
55.^Hall AC, Young BW, Bremner IIntestinal metallothionein and the mutual antagonism between copper and zinc in the ratJ Inorg Biochem.(1979 Aug)
56.^Fischer PW, Giroux A, L'Abbé MRThe effect of dietary zinc on intestinal copper absorptionAm J Clin Nutr.(1981 Sep)
57.^Kumar KS1, Dayananda S, Subramanyam CCopper alone, but not oxidative stress, induces copper-metallothionein gene in Neurospora crassaFEMS Microbiol Lett.(2005 Jan 1)
58.^Oestreicher P, Cousins RJCopper and zinc absorption in the rat: mechanism of mutual antagonismJ Nutr.(1985 Feb)
59.^Davies NT, Nightingale RThe effects of phytate on intestinal absorption and secretion of zinc, and whole-body retention of Zn, copper, iron and manganese in ratsBr J Nutr.(1975 Sep)
60.^Greger JL, Snedeker SMEffect of dietary protein and phosphorus levels on the utilization of zinc, copper and manganese by adult malesJ Nutr.(1980 Nov)
62.^MOORE T, CONSTABLE BJ, DAY KC, IMPEY SG, SYMONDS KRCOPPER DEFICIENCY IN RATS FED UPON RAW MEATBr J Nutr.(1964)
64.^Brewer GJ1, Askari F, Dick RB, Sitterly J, Fink JK, Carlson M, Kluin KJ, Lorincz MTTreatment of Wilson's disease with tetrathiomolybdate: V. Control of free copper by tetrathiomolybdate and a comparison with trientineTransl Res.(2009 Aug)
65.^Yüce A1, Koçak N, Ozen H, Gürakan FWilson's disease patients with normal ceruloplasmin levelsTurk J Pediatr.(1999 Jan-Mar)
66.^Squitti R1, Ghidoni R, Scrascia F, Benussi L, Panetta V, Pasqualetti P, Moffa F, Bernardini S, Ventriglia M, Binetti G, Rossini PMFree copper distinguishes mild cognitive impairment subjects from healthy elderly individualsJ Alzheimers Dis.(2011)
67.^Squitti R1, Polimanti RCopper phenotype in Alzheimer's disease: dissecting the pathwayAm J Neurodegener Dis.(2013 Jun 21)
69.^Hassan W1, Silva CE2, Mohammadzai IU3, da Rocha JB4, J LF2Association of oxidative stress to the genesis of anxiety: implications for possible therapeutic interventionsCurr Neuropharmacol.(2014 Mar)
70.^Sharonova IN1, Vorobjev VS, Haas HLHigh-affinity copper block of GABA(A) receptor-mediated currents in acutely isolated cerebellar Purkinje cells of the ratEur J Neurosci.(1998 Feb)
71.^Kim H1, Macdonald RLAn N-terminal histidine is the primary determinant of alpha subunit-dependent Cu2+ sensitivity of alphabeta3gamma2L GABA(A) receptorsMol Pharmacol.(2003 Nov)
73.^Islam MR1, Ahmed MU, Mitu SA, Islam MS, Rahman GK, Qusar MM, Hasnat AComparative analysis of serum zinc, copper, manganese, iron, calcium, and magnesium level and complexity of interelement relations in generalized anxiety disorder patientsBiol Trace Elem Res.(2013 Jul)
74.^Russo AJ1Decreased zinc and increased copper in individuals with anxietyNutr Metab Insights.(2011 Feb 7)
75.^Schlegel-Zawadzka M1, Zieba A, Dudek D, Zak-Knapik J, Nowak GIs serum copper a "trait marker" of unipolar depression? A preliminary clinical studyPol J Pharmacol.(1999 Nov-Dec)
76.^Chang MY1, Tseng CH, Chiou YLThe plasma concentration of copper and prevalence of depression were positively correlated in shift nursesBiol Res Nurs.(2014 Apr)
77.^Crayton JW1, Walsh WJElevated serum copper levels in women with a history of post-partum depressionJ Trace Elem Med Biol.(2007)
78.^Russo AJ1Analysis of plasma zinc and copper concentration, and perceived symptoms, in individuals with depression, post zinc and anti-oxidant therapyNutr Metab Insights.(2011 Apr 17)
80.^Allen KG, Klevay LMCopper: an antioxidant nutrient for cardiovascular healthCurr Opin Lipidol.(1994 Feb)
81.^Reunanen A, Knekt P, Aaran RKSerum ceruloplasmin level and the risk of myocardial infarction and strokeAm J Epidemiol.(1992 Nov 1)
82.^Ford ESSerum copper concentration and coronary heart disease among US adultsAm J Epidemiol.(2000 Jun 15)
83.^Cooper GJ, Young AA, Gamble GD, Occleshaw CJ, Dissanayake AM, Cowan BR, Brunton DH, Baker JR, Phillips AR, Frampton CM, Poppitt SD, Doughty RNA copper(II)-selective chelator ameliorates left-ventricular hypertrophy in type 2 diabetic patients: a randomised placebo-controlled studyDiabetologia.(2009 Apr)
84.^Lind PM, Olsén L, Lind LElevated circulating levels of copper and nickel are found in elderly subjects with left ventricular hypertrophyEcotoxicol Environ Saf.(2012 Dec)
85.^DiSilvestro RA, Joseph EL, Zhang W, Raimo AE, Kim YMA randomized trial of copper supplementation effects on blood copper enzyme activities and parameters related to cardiovascular healthMetabolism.(2012 Sep)
87.^Bügel S, Harper A, Rock E, O'Connor JM, Bonham MP, Strain JJEffect of copper supplementation on indices of copper status and certain CVD risk markers in young healthy womenBr J Nutr.(2005 Aug)
88.^Bagheri B, Akbari N, Tabiban S, Habibi V, Mokhberi VSerum level of copper in patients with coronary artery diseaseNiger Med J.(2015 Jan-Feb)
89.^Iskra M, Majewski W, Piorunska-Stolzmann MModifications of magnesium and copper concentrations in serum and arterial wall of patients with vascular diseases related to ageing, atherosclerosis and aortic aneurysmMagnes Res.(2002 Dec)
90.^Russo C, Olivieri O, Girelli D, Faccini G, Zenari ML, Lombardi S, Corrocher RAnti-oxidant status and lipid peroxidation in patients with essential hypertensionJ Hypertens.(1998 Sep)
91.^Jones AA, DiSilvestro RA, Coleman M, Wagner TLCopper supplementation of adult men: effects on blood copper enzyme activities and indicators of cardiovascular disease riskMetabolism.(1997 Dec)
92.^Rojas-Sobarzo L, Olivares M, Brito A, Suazo M, Araya M, Pizarro FCopper supplementation at 8 mg neither affects circulating lipids nor liver function in apparently healthy Chilean menBiol Trace Elem Res.(2013 Dec)
93.^Turley E, McKeown A, Bonham MP, O'Connor JM, Chopra M, Harvey LJ, Majsak-Newman G, Fairweather-Tait SJ, Bügel S, Sandström B, Rock E, Mazur A, Rayssiguier Y, Strain JJCopper supplementation in humans does not affect the susceptibility of low density lipoprotein to in vitro induced oxidation (FOODCUE project)Free Radic Biol Med.(2000 Dec)
95.^Kazi TG1, Afridi HI, Kazi N, Jamali MK, Arain MB, Jalbani N, Kandhro GACopper, chromium, manganese, iron, nickel, and zinc levels in biological samples of diabetes mellitus patientsBiol Trace Elem Res.(2008 Apr)
96.^Ekmekcioglu C1, Prohaska C, Pomazal K, Steffan I, Schernthaner G, Marktl WConcentrations of seven trace elements in different hematological matrices in patients with type 2 diabetes as compared to healthy controlsBiol Trace Elem Res.(2001 Mar)
97.^Walter RM Jr1, Uriu-Hare JY, Olin KL, Oster MH, Anawalt BD, Critchfield JW, Keen CLCopper, zinc, manganese, and magnesium status and complications of diabetes mellitusDiabetes Care.(1991 Nov)
98.^Savu O1, Ionescu-Tirgoviste C, Atanasiu V, Gaman L, Papacocea R, Stoian IIncrease in total antioxidant capacity of plasma despite high levels of oxidative stress in uncomplicated type 2 diabetes mellitusJ Int Med Res.(2012)
99.^Aguilar MV1, Saavedra P, Arrieta FJ, Mateos CJ, González MJ, Meseguer I, Martínez-Para MCPlasma mineral content in type-2 diabetic patients and their association with the metabolic syndromeAnn Nutr Metab.(2007)
100.^Williams NR1, Rajput-Williams J, West JA, Nigdikar SV, Foote JW, Howard ANPlasma, granulocyte and mononuclear cell copper and zinc in patients with diabetes mellitusAnalyst.(1995 Mar)
101.^Viktorínová A1, Toserová E, Krizko M, Duracková ZAltered metabolism of copper, zinc, and magnesium is associated with increased levels of glycated hemoglobin in patients with diabetes mellitusMetabolism.(2009 Oct)
102.^Wills NK1, Ramanujam VM, Kalariya N, Lewis JR, van Kuijk FJCopper and zinc distribution in the human retina: relationship to cadmium accumulation, age, and genderExp Eye Res.(2008 Aug)
103.^Behndig A1, Svensson B, Marklund SL, Karlsson KSuperoxide dismutase isoenzymes in the human eyeInvest Ophthalmol Vis Sci.(1998 Mar)
104.^Gahlot DK, Ratnakar KSEffect of experimentally induced chronic copper toxicity on retinaIndian J Ophthalmol.(1981 Dec)
105.^Wills NK1, Ramanujam VM, Chang J, Kalariya N, Lewis JR, Weng TX, van Kuijk FJCadmium accumulation in the human retina: effects of age, gender, and cellular toxicityExp Eye Res.(2008 Jan)
106.^Zampatti S1, Ricci F2, Cusumano A2, Marsella LT1, Novelli G3, Giardina E4Review of nutrient actions on age-related macular degenerationNutr Res.(2014 Feb)
107.^Age-Related Eye Disease Study Research GroupThe Age-Related Eye Disease Study (AREDS): design implications. AREDS report no. 1Control Clin Trials.(1999 Dec)
108.^Age-Related Eye Disease Study Research GroupA randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8Arch Ophthalmol.(2001 Oct)
109.^Sin HP1, Liu DT, Lam DSLifestyle modification, nutritional and vitamins supplements for age-related macular degenerationActa Ophthalmol.(2013 Feb)
110.^Gordon SA1, Lominadze D, Saari JT, Lentsch AB, Schuschke DAImpaired deformability of copper-deficient neutrophilsExp Biol Med (Maywood).(2005 Sep)
111.^Lominadze D1, Saari JT, Percival SS, Schuschke DAProinflammatory effects of copper deficiency on neutrophils and lung endothelial cellsImmunol Cell Biol.(2004 Jun)
112.^Wagner D1, Maser J, Lai B, Cai Z, Barry CE 3rd, Höner Zu Bentrup K, Russell DG, Bermudez LEElemental analysis of Mycobacterium avium-, Mycobacterium tuberculosis-, and Mycobacterium smegmatis-containing phagosomes indicates pathogen-induced microenvironments within the host cell's endosomal systemJ Immunol.(2005 Feb 1)
113.^Babu U1, Failla MLRespiratory burst and candidacidal activity of peritoneal macrophages are impaired in copper-deficient ratsJ Nutr.(1990 Dec)
114.^Suttle NF1, Jones DGRecent developments in trace element metabolism and function: trace elements, disease resistance and immune responsiveness in ruminantsJ Nutr.(1989 Jul)
115.^Leary SC1, Winge DRThe Janus face of copper: its expanding roles in biology and the pathophysiology of disease. Meeting on Copper and Related Metals in BiologyEMBO Rep.(2007 Mar)
116.^White C1, Lee J, Kambe T, Fritsche K, Petris MJA role for the ATP7A copper-transporting ATPase in macrophage bactericidal activityJ Biol Chem.(2009 Dec 4)
117.^Pyo HK1, Yoo HG, Won CH, Lee SH, Kang YJ, Eun HC, Cho KH, Kim KHThe effect of tripeptide-copper complex on human hair growth in vitroArch Pharm Res.(2007 Jul)
118.^Kil MS, Kim CW, Kim SSAnalysis of serum zinc and copper concentrations in hair lossAnn Dermatol.(2013 Nov)
119.^Bhat YJ1, Manzoor S, Khan AR, Qayoom STrace element levels in alopecia areataIndian J Dermatol Venereol Leprol.(2009 Jan-Feb)
120.^Ozturk P1, Kurutas E2, Ataseven A3, Dokur N4, Gumusalan Y5, Gorur A6, Tamer L7, Inaloz S8BMI and levels of zinc, copper in hair, serum and urine of Turkish male patients with androgenetic alopeciaJ Trace Elem Med Biol.(2014 Jul)
121.^Turok DK1, Jacobson JC2, Dermish AI2, Simonsen SE3, Gurtcheff S4, McFadden M5, Murphy PA6Emergency contraception with a copper IUD or oral levonorgestrel: an observational study of 1-year pregnancy ratesContraception.(2014 Mar)
122.^Farr G1, Amatya RContraceptive efficacy of the Copper T380A and the Multiload Cu250 IUD in three developing countriesAdv Contracept.(1994 Jun)
123.^Yu J1, Li J, Li HG, Li JX, Xie CS, Zhu CHComparative study on contraceptive efficacy and clinical performance of the copper/low-density polyethylene nanocomposite IUD and the copper T220C IUDContraception.(2008 Oct)
124.^Andrade AT1, Pizarro E, Shaw ST Jr, Souza JP, Belsey EM, Rowe PJConsequences of uterine blood loss caused by various intrauterine contraceptive devices in South American women. World Health Organization Special Programme of Research, Development and Research Training in Human ReproductionContraception.(1988 Jul)
125.^Sivin I1, Stern J, Diaz S, Pavéz M, Alvarez F, Brache V, Mishell DR Jr, Lacarra M, McCarthy T, Holma P, et alRates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devicesAm J Obstet Gynecol.(1992 Apr)
126.^Godfrey EM1, Folger SG, Jeng G, Jamieson DJ, Curtis KMTreatment of bleeding irregularities in women with copper-containing IUDs: a systematic reviewContraception.(2013 May)
127.^Bush AI1, Tanzi RETherapeutics for Alzheimer's disease based on the metal hypothesisNeurotherapeutics.(2008 Jul)
128.^Bucossi S1, Ventriglia M, Panetta V, Salustri C, Pasqualetti P, Mariani S, Siotto M, Rossini PM, Squitti RCopper in Alzheimer's disease: a meta-analysis of serum,plasma, and cerebrospinal fluid studiesJ Alzheimers Dis.(2011)
129.^Brewer GJ1The risks of copper toxicity contributing to cognitive decline in the aging population and to Alzheimer's diseaseJ Am Coll Nutr.(2009 Jun)
130.^Madarić A1, Ginter E, Kadrabová JSerum copper, zinc and copper/zinc ratio in males: influence of agingPhysiol Res.(1994)
131.^Vasudevaraju P1, Bharathi, T J, Shamasundar NM, Subba Rao K, Balaraj BM, Ksj R, T S SRNew evidence on iron, copper accumulation and zinc depletion and its correlation with DNA integrity in aging human brain regionsIndian J Psychiatry.(2010 Apr)
132.^Mao X1, Ye J, Zhou S, Pi R, Dou J, Zang L, Chen X, Chao X, Li W, Liu M, Liu PThe effects of chronic copper exposure on the amyloid protein metabolisim associated genes' expression in chronic cerebral hypoperfused ratsNeurosci Lett.(2012 Jun 14)
133.^Ceccom J1, Coslédan F, Halley H, Francès B, Lassalle JM, Meunier BCopper chelator induced efficient episodic memory recovery in a non-transgenic Alzheimer's mouse modelPLoS One.(2012)
134.^White AR1, Multhaup G, Maher F, Bellingham S, Camakaris J, Zheng H, Bush AI, Beyreuther K, Masters CL, Cappai RThe Alzheimer's disease amyloid precursor protein modulates copper-induced toxicity and oxidative stress in primary neuronal culturesJ Neurosci.(1999 Nov 1)
135.^Wang H1, Wang M, Wang B, Li M, Chen H, Yu X, Zhao Y, Feng W, Chai ZThe distribution profile and oxidation states of biometals in APP transgenic mouse brain: dyshomeostasis with age and as a function of the development of Alzheimer's diseaseMetallomics.(2012 Mar)
136.^Yoshiike Y1, Tanemura K, Murayama O, Akagi T, Murayama M, Sato S, Sun X, Tanaka N, Takashima ANew insights on how metals disrupt amyloid beta-aggregation and their effects on amyloid-beta cytotoxicityJ Biol Chem.(2001 Aug 24)
137.^Huang X1, Atwood CS, Hartshorn MA, Multhaup G, Goldstein LE, Scarpa RC, Cuajungco MP, Gray DN, Lim J, Moir RD, Tanzi RE, Bush AIThe A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reductionBiochemistry.(1999 Jun 15)
138.^Dikalov SI1, Vitek MP, Mason RPCupric-amyloid beta peptide complex stimulates oxidation of ascorbate and generation of hydroxyl radicalFree Radic Biol Med.(2004 Feb 1)
139.^Huang X1, Cuajungco MP, Atwood CS, Hartshorn MA, Tyndall JD, Hanson GR, Stokes KC, Leopold M, Multhaup G, Goldstein LE, Scarpa RC, Saunders AJ, Lim J, Moir RD, Glabe C, Bowden EF, Masters CL, Fairlie DP, Tanzi RE, Bush AICu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reductionJ Biol Chem.(1999 Dec 24)
140.^Barnham KJ1, Masters CL, Bush AINeurodegenerative diseases and oxidative stressNat Rev Drug Discov.(2004 Mar)
141.^Dai XL1, Sun YX, Jiang ZFCu(II) potentiation of Alzheimer Abeta1-40 cytotoxicity and transition on its secondary structureActa Biochim Biophys Sin (Shanghai).(2006 Nov)
142.^Squitti R1, Polimanti RCopper hypothesis in the missing hereditability of sporadic Alzheimer's disease: ATP7B gene as potential harbor of rare variantsJ Alzheimers Dis.(2012)
143.^Squitti R1, Polimanti R, Bucossi S, Ventriglia M, Mariani S, Manfellotto D, Vernieri F, Cassetta E, Ursini F, Rossini PMLinkage disequilibrium and haplotype analysis of the ATP7B gene in Alzheimer's diseaseRejuvenation Res.(2013 Feb)
146.^Palmiter RD1Regulation of metallothionein genes by heavy metals appears to be mediated by a zinc-sensitive inhibitor that interacts with a constitutively active transcription factor, MTF-1Proc Natl Acad Sci U S A.(1994 Feb 15)
147.^Heuchel R1, Radtke F, Georgiev O, Stark G, Aguet M, Schaffner WThe transcription factor MTF-1 is essential for basal and heavy metal-induced metallothionein gene expressionEMBO J.(1994 Jun 15)
148.^Klaassen CD1, Liu J, Choudhuri SMetallothionein: an intracellular protein to protect against cadmium toxicityAnnu Rev Pharmacol Toxicol.(1999)
149.^Aschner M1, Syversen T, Souza DO, Rocha JBMetallothioneins: mercury species-specific induction and their potential role in attenuating neurotoxicityExp Biol Med (Maywood).(2006 Oct)
150.^Willis MS1, Monaghan SA, Miller ML, McKenna RW, Perkins WD, Levinson BS, Bhushan V, Kroft SHZinc-induced copper deficiency: a report of three cases initially recognized on bone marrow examinationAm J Clin Pathol.(2005 Jan)
151.^Afrin LB1Fatal copper deficiency from excessive use of zinc-based denture adhesiveAm J Med Sci.(2010 Aug)
152.^Nations SP1, Boyer PJ, Love LA, Burritt MF, Butz JA, Wolfe GI, Hynan LS, Reisch J, Trivedi JRDenture cream: an unusual source of excess zinc, leading to hypocupremia and neurologic diseaseNeurology.(2008 Aug 26)
153.^Prodan CI1, Holland NR, Wisdom PJ, Burstein SA, Bottomley SSCNS demyelination associated with copper deficiency and hyperzincemiaNeurology.(2002 Nov 12)
156.^Baker DH, Czarnecki-Maulden GLPharmacologic role of cysteine in ameliorating or exacerbating mineral toxicitiesJ Nutr.(1987 Jun)
157.^Van Campen D, Gross EInfluence of ascorbic acid on the absorption of copper by ratsJ Nutr.(1968 Aug)
158.^Aoyagi S1, Baker DHCopper-amino acid complexes are partially protected against inhibitory effects of L-cysteine and L-ascorbic acid on copper absorption in chicksJ Nutr.(1994 Mar)
Primary Use
Secondary Use